Tacking. Subject to the truth and accuracy of the Investor’s representations set forth in Section 4 of this Agreement, the parties acknowledge and agree that in accordance with Section 3(a) (9) of the Securities Act, the Exchange Securities issued in exchange for the Debentures will tack back to the original issue dates of each of the Existing Securities pursuant to Rule 144 and the Company agrees not to take a position to the contrary.
Appears in 2 contracts
Sources: Exchange Agreement (GeoVax Labs, Inc.), Exchange Agreement (GeoVax Labs, Inc.)
Tacking. Subject to the truth and accuracy of the Investor’s representations set forth in Section 4 6 of this Agreement, the parties acknowledge and agree that in accordance with Section 3(a) (93(a)(9) of the Securities Act, the Exchange Securities issued in exchange for the Debentures Existing Securities will tack back to the original issue dates of each of the Existing Securities pursuant to Rule 144 and the Company agrees not to take a position to the contrary.
Appears in 2 contracts
Sources: Exchange Agreement (PARETEUM Corp), Exchange Agreement (PARETEUM Corp)
Tacking. Subject to the truth and accuracy of the Investor’s representations set forth in Section 4 of this Agreement, the parties acknowledge and agree that in accordance with Section 3(a) (93(a)(9) of the Securities Act, the Exchange Securities issued in exchange Exchange for the Bridge Debentures will tack back to the original issue dates of each of the Existing Securities such Bridge Debentures pursuant to Rule 144 and the Company agrees not to take a position to the contrary.
Appears in 2 contracts
Sources: Exchange Agreement, Exchange Agreement (Rennova Health, Inc.)
Tacking. Subject to the truth and accuracy of the Investor’s representations set forth in Section 4 of this Agreement, the parties acknowledge and agree that in accordance with Section 3(a) (93(a)(9) of the Securities Act, the Exchange Securities issued in exchange Exchange for the Debentures will tack back to the original issue dates of each of the Existing Securities such Debentures pursuant to Rule 144 and the Company agrees not to take a position to the contrary.
Appears in 1 contract
Tacking. Subject to the truth and accuracy of the Investor’s representations set forth in Section 4 of this Agreement, the parties acknowledge and agree that in accordance with Section 3(a) (9) of the Securities Act, the Exchange Securities issued in exchange for the Debentures Existing Securities will tack back to the original issue dates of each of the Existing Securities pursuant to Rule 144 and the Company agrees not to take a position to the contrary.
Appears in 1 contract
Tacking. Subject to the truth and accuracy of the Investor’s representations set forth in Section 4 of this Agreement, the parties acknowledge and agree that in accordance with Section 3(a) (93(a)(9) of the Securities Act, the Exchange Securities issued in exchange for the Debentures Exchange will tack back to the original issue dates of each date of the Existing Securities pursuant to Rule 144 and the Company agrees not to take a position to the contrary.
Appears in 1 contract
Tacking. Subject to the truth and accuracy of the Investor’s representations set forth in Section 4 5 of this Agreement, the parties acknowledge and agree that in accordance with Section 3(a) (93(a)(9) of the Securities Act, the Exchange Securities issued in exchange for the Debentures Warrants will tack back to the original issue dates of each date of the Existing Securities Warrants pursuant to Rule 144 and the Company agrees not to take a position to the contrary.
Appears in 1 contract
Sources: Exchange Agreement (Creative Medical Technology Holdings, Inc.)